
Hematology-Oncologyiron therapystillbirth prevention
Hematologic Response to Iron Therapy and Stillbirth Risk in Moderate Iron Deficiency Anemia
By MedXY|Aug 18, 2026
Study reveals inadequate hemoglobin improvement at 20-24 weeks after iron therapy increases stillbirth and preterm birth risks in moderate iron deficiency anemia pregnancies, highlighting need for early intervention.